Xin Hou Selected Research

(4,4)- biphenylalanyl- threonyl- seryl- tyrosyl- glutamyl- alanyl- leucyl- lysyl- lysine

1/2013

Restoration of renal function by a novel prostaglandin EP4 receptor-derived peptide in models of acute renal failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xin Hou Research Topics

Disease

21	Neoplasms (Cancer) 07/2022 - 10/2003
16	Inflammation (Inflammations) 07/2022 - 10/2003
10	Infections 12/2020 - 06/2012
8	Premature Birth (Birth, Premature) 01/2019 - 07/2015
7	Fibrosis (Cirrhosis) 01/2021 - 02/2012
6	Hepatocellular Carcinoma (Hepatoma) 06/2016 - 10/2003
5	COVID-19 01/2021 - 11/2020
5	Premature Obstetric Labor (Premature Labor) 01/2019 - 12/2002
5	Granuloma 01/2019 - 02/2012
4	Ischemia 01/2022 - 02/2014
3	Wounds and Injuries (Trauma) 07/2022 - 01/2020
3	Osteoporosis 01/2022 - 02/2019
3	Graves Disease (Basedow Disease) 01/2022 - 12/2011
3	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2020 - 01/2018
3	Hypothyroidism 01/2020 - 02/2011
3	Invasive Candidiasis 01/2018 - 01/2017
3	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 01/2017 - 06/2011
3	Retinal Neovascularization 01/2016 - 04/2006
3	Liver Cirrhosis (Hepatic Cirrhosis) 07/2015 - 01/2012
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2014 - 05/2008
2	Lung Neoplasms (Lung Cancer) 01/2022 - 08/2015
2	Infarction (Infarctions) 01/2022 - 02/2014
2	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 01/2013
2	Hypoxia (Hypoxemia) 01/2021 - 02/2014
2	Clostridium Infections 07/2020 - 01/2015
2	Rheumatoid Arthritis 01/2019 - 11/2014
2	Thyroid Diseases (Thyroid Disease) 01/2017 - 06/2011
2	Schistosomiasis japonica 07/2015 - 02/2012
2	Schistosomiasis (Bilharziasis) 07/2015 - 01/2014
2	Massive Hepatic Necrosis 02/2015 - 03/2009
2	Brain Injuries (Brain Injury) 02/2014 - 10/2008
2	Hypercapnia 06/2010 - 05/2002
2	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 04/2003 - 03/2003
1	Autoimmune Diseases (Autoimmune Disease) 08/2022
1	Metabolic Diseases (Metabolic Disease) 08/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2022
1	Chronic Hepatitis B 08/2022
1	Hemorrhage 07/2022
1	Schizophrenia (Dementia Praecox) 06/2022

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2002
7	Pharmaceutical PreparationsIBA 01/2022 - 03/2016
6	Peptides (Polypeptides)IBA 01/2021 - 10/2008
6	AntibodiesIBA 01/2021 - 10/2003
6	CytokinesIBA 01/2021 - 06/2012
4	Biomarkers (Surrogate Marker)IBA 03/2022 - 02/2015
4	Retinaldehyde (Retinal)IBA 04/2020 - 05/2002
4	ProstaglandinsIBA 01/2019 - 05/2002
4	Interleukin-10 (Interleukin 10)IBA 01/2019 - 02/2012
4	Interleukin-1 (Interleukin 1)IBA 01/2019 - 10/2008
3	Immune Checkpoint InhibitorsIBA 08/2022 - 03/2022
3	LipidsIBA 01/2022 - 02/2011
3	Immunoglobulin M (IgM)IBA 01/2021 - 12/2020
3	Immunoglobulin G (IgG)IBA 01/2021 - 12/2020
3	Amino Acids FDA Link 12/2020 - 09/2011
3	NanocapsulesIBA 09/2020 - 05/2018
3	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2020 - 10/2008
3	corticosteroid hormone-induced factorIBA 01/2020 - 01/2018
3	ChemokinesIBA 10/2019 - 06/2012
3	AzolesIBA 01/2018 - 01/2017
3	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2018 - 10/2008
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2017 - 05/2013
3	Tocolytic Agents (Tocolytics)IBA 01/2017 - 09/2011
3	Poly I-CIBA 02/2012 - 03/2009
2	oxidized low density lipoproteinIBA 06/2022 - 02/2011
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2021
2	Therapeutic UsesIBA 01/2022 - 01/2017
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2022 - 01/2017
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2017
2	TRPC6 Cation ChannelIBA 01/2021 - 01/2020
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 01/2019
2	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 03/2019
2	ProteomeIBA 01/2021 - 12/2020
2	EnzymesIBA 12/2020 - 08/2020
2	EchinocandinsIBA 08/2020 - 01/2018
2	Polysaccharides (Glycans)IBA 10/2019 - 02/2019
2	Messenger RNA (mRNA)IBA 10/2019 - 02/2012
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2019 - 07/2015
2	Alanine Transaminase (SGPT)IBA 01/2019 - 03/2013
2	CollagenIBA 01/2019 - 07/2015
2	EndotoxinsIBA 01/2017 - 12/2002
2	LigandsIBA 09/2016 - 10/2015
2	platelet activating factor receptorIBA 01/2016 - 01/2016
2	AutoantibodiesIBA 10/2015 - 12/2011
2	Interleukin-17 (Interleukin 17)IBA 07/2015 - 06/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2015 - 04/2006
2	GalactosamineIBA 02/2015 - 03/2009
2	Interleukin-12 (IL 12)IBA 11/2014 - 02/2012
2	boswellic acidIBA 01/2014 - 03/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014 - 09/2010
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 02/2011 - 01/2011
1	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 08/2022
1	MicrogelsIBA 07/2022
1	PowdersIBA 07/2022
1	Monoclonal AntibodiesIBA 07/2022
1	Hemostatics (Antihemorrhagics)IBA 07/2022
1	HydrogelsIBA 07/2022
1	ChitosanIBA 07/2022

Therapy/Procedure

18	Therapeutics 07/2022 - 01/2006
3	Immunotherapy 07/2022 - 01/2017
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2014